Ganirelix Acetate
NDC 67184-0574, Ganirelix Acetate, injection, solution, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0574
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218855
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0574 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANIRELIX ACETATE250 ug/.5mL
Pharmacologic classes
Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0574-1 | 67184057401 | 1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/440f6d67-f02e-4407-8830-39c394e25e5d
Use it
Look up 67184-0574 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0574 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0574. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.